BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2027242)

  • 1. [Aggressive natural killer cell lymphoproliferative disease of large granular lymphocytes with leukemia-like clinical course in the terminalstage].
    Tsukada T; Ohno T; Morita K; Otsuji H; Sekine T; Nishikawa M; Kobayashi T; Kita K; Shirakawa S; Namba K
    Rinsho Ketsueki; 1991 Feb; 32(2):162-6. PubMed ID: 2027242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative process with natural killer cell phenotype. Histopathologic, ultrastructural, and surface marker observations.
    Abenoza P; Parkin J; Bowers S; Gajl-Peczalska KJ
    Arch Pathol Lab Med; 1993 Aug; 117(8):851-5. PubMed ID: 8343054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoproliferative disorder of granular lymphocytes. A heterogeneous disease.
    McDaniel HL; MacPherson BR; Tindle BH; Lunde JH
    Arch Pathol Lab Med; 1992 Mar; 116(3):242-8. PubMed ID: 1371379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
    Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement.
    Aoyama Y; Yamane T; Hino M; Ohta K; Nakamae H; Yamamura R; Koh KR; Takubo T; Inoue T; Tatsumi Y; Tatsumi N
    Ann Hematol; 2001 Dec; 80(12):752-4. PubMed ID: 11797118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphoproliferative disease of large granular lymphocytes.
    Vahancík A; Babusíková O; Ujházy P; Klobusická M; Jakubovský J; Izakovic V
    Neoplasma; 1988; 35(1):81-9. PubMed ID: 3352841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD16+ NK lymphoproliferative disorders: cellular and molecular characterization.
    Landay A; Gebel H; Levin S; Prasthofer E; Pistoia V; Downing J; Grossi C
    Nat Immun Cell Growth Regul; 1987; 6(3):141-9. PubMed ID: 3114622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genotypic heterogeneity in large granular lymphocyte expansion.
    Loiseau P; Divine M; Le Paslier D; Marolleau JP; Farcet JP; Flandrin G; Cohen D; Degos L; Sigaux F; Reyes F
    Leukemia; 1987 Mar; 1(3):205-9. PubMed ID: 3669743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Granular lymphocyte leukemia of natural killer cell type; association with 47 XY, +8 by interleukin 2 (IL-2)-stimulated chromosomal analysis].
    Ishida F; Saitoh H; Furihata K; Furuta S; Sonoyama M; Oshimi K
    Rinsho Ketsueki; 1990 Oct; 31(10):1711-5. PubMed ID: 2255062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aggressive large granular lymphocyte leukemia with E+, CD2+, CD3-, CD8-, CD16-, OKM1-, OKT10+, OKIa-1+ and Leu7- surface phenotype].
    Maekawa T; Fujii H; Doi S; Takahashi T; Taniwaki M; Urata Y; Kita K
    Rinsho Ketsueki; 1988 Dec; 29(12):2323-8. PubMed ID: 3246718
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
    Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
    Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aggressive NK cell leukemia/lymphoma: an autopsy case].
    Takai K; Sanada M
    Rinsho Ketsueki; 2001 Aug; 42(8):621-6. PubMed ID: 11579501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [NK- and T-cell granular lymphocyte-proliferative disorders].
    Sakata T; Amano M; Yamada K; Oshimi K; Kobayashi Y; Togawa A
    Rinsho Ketsueki; 1990 Apr; 31(4):462-7. PubMed ID: 2381062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF).
    Nicholson-Weller A; Russian DA; Austen KF
    J Immunol; 1986 Aug; 137(4):1275-9. PubMed ID: 3090145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.